Antithrombotic strategies for atrial fibrillation: on the threshold of changes? No.
Pengo
V
V
Clinical Cardiology, Thrombosis Center, University of Padova, School of Medicine, Padova, Italy. vittorio.pengo@unipd.it
D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D005343:Fibrinolytic Agents